B Taylor Thompson Selected Research

Mechanical Ventilators (Ventilator)

7/2021	Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure.
1/2021	Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.
1/2020	Alive and Ventilator Free: A Hierarchical, Composite Outcome for Clinical Trials in the Acute Respiratory Distress Syndrome.
1/2020	Ventilator Sharing during an Acute Shortage Caused by the COVID-19 Pandemic.
10/2017	Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
10/2017	Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
9/2016	Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome.
4/2016	Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome.
10/2015	Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.
8/2014	Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B Taylor Thompson Research Topics

Disease

57	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2000
40	Acute Lung Injury 10/2022 - 01/2000
26	Sepsis (Septicemia) 01/2021 - 04/2003
19	Critical Illness (Critically Ill) 01/2022 - 04/2003
17	COVID-19 10/2022 - 01/2020
15	Lung Injury 01/2022 - 01/2000
14	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2007
13	Inflammation (Inflammations) 01/2022 - 01/2005
13	Infections 01/2022 - 01/2008
13	Shock 01/2017 - 08/2004
9	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2002
7	Body Weight (Weight, Body) 01/2017 - 01/2000
6	Hypoxia (Hypoxemia) 10/2022 - 08/2003
6	Hypotension (Low Blood Pressure) 01/2022 - 05/2006
5	Heart Failure 01/2021 - 08/2003
4	Pneumonia (Pneumonitis) 12/2015 - 04/2003
4	Pulmonary Edema 09/2011 - 08/2007
3	Lung Diseases (Lung Disease) 01/2022 - 01/2012
3	Neoplasms (Cancer) 01/2022 - 09/2010
3	Barotrauma 10/2017 - 04/2002
3	Wounds and Injuries (Trauma) 09/2014 - 06/2005
3	Acute Kidney Injury (Acute Renal Failure) 12/2011 - 12/2007
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2008 - 04/2003
3	Cardiogenic Shock 02/2006 - 08/2003
2	Human Influenza (Influenza) 05/2016 - 04/2010
2	Liver Failure 06/2014 - 04/2002
2	Chronic Renal Insufficiency 12/2012 - 02/2012
2	Hyperglycemia 08/2012 - 05/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 01/2008
2	Hemorrhage 01/2008 - 01/2008
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2008 - 01/2008
2	Ulcer 01/2008 - 01/2008

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2006
11	Protein CIBA 10/2013 - 08/2007
9	Oxygen (Dioxygen)IBA 10/2022 - 07/2004
8	Biological ProductsIBA 01/2022 - 10/2007
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2005
5	SteroidsIBA 05/2016 - 04/2003
5	Insulin (Novolin)FDA Link 12/2015 - 05/2008
5	von Willebrand FactorIBA 06/2012 - 10/2004
4	CreatinineIBA 01/2022 - 12/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2008
4	AntigensIBA 01/2022 - 10/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 05/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2016 - 01/2008
4	drotrecogin alfa activated (Xigris)FDA Link 04/2015 - 11/2008
4	Interleukin-8 (Interleukin 8)IBA 06/2010 - 01/2005
4	Blood Glucose (Blood Sugar)IBA 06/2008 - 01/2008
3	VaccinesIBA 10/2022 - 04/2021
3	Antiviral Agents (Antivirals)IBA 04/2022 - 04/2021
3	Monoclonal AntibodiesIBA 01/2022 - 11/2021
3	bamlanivimabIBA 01/2022 - 11/2021
3	Vitamin D FDA LinkGeneric 12/2019 - 02/2012
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 01/2008
3	Crystalloid SolutionsIBA 07/2014 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 09/2010 - 05/2008
3	Surface-Active Agents (Surfactants)IBA 02/2010 - 01/2004
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 02/2010 - 10/2007
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010 - 10/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 10/2007
3	Neuromuscular Blocking AgentsIBA 04/2008 - 01/2008
2	remdesivirIBA 01/2022 - 11/2021
2	C-Reactive ProteinIBA 07/2021 - 08/2009
2	TroponinIBA 04/2021 - 11/2007
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020 - 01/2020
2	Carbon MonoxideIBA 12/2018 - 10/2015
2	Rosuvastatin Calcium (Crestor)FDA Link 11/2018 - 06/2014
2	GlucocorticoidsIBA 11/2016 - 04/2003
2	Albuterol (Salbutamol)FDA LinkGeneric 09/2014 - 09/2011
2	AlbuminsIBA 07/2014 - 06/2005
2	Troponin T (Troponin T1)IBA 04/2014 - 01/2012
2	paricalcitol (Zemplar)FDA Link 12/2012 - 02/2012
2	Angiopoietin-2IBA 06/2012 - 06/2009
2	Vasodilator Agents (Vasodilators)IBA 02/2010 - 08/2003
2	Plasminogen Activator Inhibitor 1IBA 02/2010 - 12/2007
2	IgA receptor (protein B)IBA 09/2008 - 01/2004
2	Natriuretic PeptidesIBA 08/2008 - 02/2006
2	pro-brain natriuretic peptide (1-76)IBA 08/2008 - 02/2006
2	Colloids (Colloid)IBA 01/2008 - 01/2008
2	Hemoglobins (Hemoglobin)IBA 01/2008 - 01/2008
2	Dopamine (Intropin)FDA LinkGeneric 01/2008 - 01/2008
2	Dobutamine FDA LinkGeneric 01/2008 - 01/2008
2	Proton Pump InhibitorsIBA 01/2008 - 01/2008

Therapy/Procedure

35	Therapeutics 10/2022 - 04/2003
30	Mechanical Ventilators (Ventilator) 07/2021 - 01/2000
28	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2000
12	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2020 - 04/2002
9	Catheters 09/2016 - 02/2006
8	Critical Care (Surgical Intensive Care) 01/2022 - 04/2010
6	Resuscitation 03/2017 - 01/2008
3	Length of Stay 09/2010 - 01/2008
3	Renal Dialysis (Hemodialysis) 07/2008 - 01/2008
3	Glycemic Control 06/2008 - 01/2008
3	Analgesia 01/2008 - 08/2004
2	Extracorporeal Membrane Oxygenation 01/2020 - 01/2018
2	Noninvasive Ventilation 01/2017 - 02/2016
2	Enteral Nutrition (Feeding, Tube) 02/2012 - 10/2011
2	Hemofiltration 01/2008 - 01/2008